Antonio González-Martín Selected Research

Antonio González-Martín Research Topics

Disease

50	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 03/2002
25	Neoplasms (Cancer) 05/2024 - 06/2009
10	Disease Progression 02/2024 - 01/2016
7	Neutropenia 01/2023 - 06/2014
7	Ovarian Epithelial Carcinoma 01/2023 - 06/2010
6	Breast Neoplasms (Breast Cancer) 06/2023 - 12/2006
4	Vomiting 02/2024 - 07/2016
4	Nausea 02/2024 - 07/2016
4	Body Weight (Weight, Body) 01/2024 - 12/2019
4	Fatigue 01/2023 - 01/2016
4	Thrombocytopenia (Thrombopenia) 01/2023 - 06/2014
4	Fallopian Tube Neoplasms 01/2022 - 01/2016
4	Endometrial Neoplasms (Endometrial Cancer) 02/2021 - 12/2015
4	Hypertension (High Blood Pressure) 01/2017 - 09/2009
3	Asthenia 01/2023 - 01/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 09/2008
3	Anemia 10/2021 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 02/2021
2	Proteinuria 01/2017 - 09/2009
2	Diarrhea 07/2016 - 01/2016
1	Constipation 02/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	COVID-19 01/2021
1	Adenocarcinoma 01/2021
1	Dysgeusia (Parageusia) 07/2016
1	Pneumonia (Pneumonitis) 07/2016
1	Inflammation (Inflammations) 07/2016
1	Hypothyroidism 03/2016
1	Infections 01/2016
1	Alopecia (Baldness) 06/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2014
1	Febrile Neutropenia 06/2014
1	Obesity 07/2010
1	Type 2 Diabetes Mellitus (MODY) 07/2010

Drug/Important Bio-Agent (IBA)

28	PlatinumIBA 05/2024 - 03/2002
12	niraparibIBA 03/2024 - 12/2016
11	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2023 - 01/2020
10	olaparibIBA 01/2023 - 12/2018
9	Bevacizumab (Avastin)FDA Link 08/2023 - 09/2009
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2018
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 12/2016
5	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 11/2016
3	pembrolizumabIBA 05/2024 - 01/2022
3	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2014
3	TrabectedinIBA 01/2021 - 11/2016
3	taxaneIBA 12/2019 - 06/2014
2	rucaparibIBA 08/2023 - 11/2022
2	Poly Adenosine Diphosphate RiboseIBA 01/2023 - 12/2019
2	tisotumab vedotinIBA 01/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 07/2021 - 01/2021
2	AnaphylatoxinsIBA 07/2021 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2014
2	Gemcitabine FDA Link 01/2021 - 01/2016
2	Adenosine Diphosphate (ADP)IBA 12/2019 - 12/2016
2	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019 - 12/2016
1	lenvatinibIBA 05/2024
1	trastuzumab deruxtecanIBA 10/2023
1	Epidermal Growth Factor (EGF)IBA 10/2023
1	anetumab ravtansineIBA 01/2023
1	MesothelinIBA 01/2023
1	Complement C5a (Complement 5a)IBA 01/2021
1	TabletsIBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	LigandsIBA 12/2019
1	Endothelial Growth FactorsIBA 12/2019
1	1-dodecylpyridoxal (PLD)IBA 01/2019
1	gedatolisibIBA 07/2016
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 07/2016
1	StathminIBA 07/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2016
1	cediranib (AZD2171)IBA 03/2016
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Hormones (Hormone)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2016
1	pertuzumabIBA 01/2016
1	Estrogen ReceptorsIBA 06/2015
1	ErbB Receptors (EGF Receptor)IBA 06/2015
1	Growth Hormone (Somatotropin)IBA 06/2015
1	Lapatinib (GW572016)FDA Link 06/2014
1	Trastuzumab (Herceptin)FDA Link 06/2014
1	Tyrosine Kinase InhibitorsIBA 06/2014
1	Ado-Trastuzumab EmtansineIBA 06/2014
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2010

Therapy/Procedure

33	Therapeutics 05/2024 - 06/2009
26	Drug Therapy (Chemotherapy) 03/2024 - 08/2011
4	Neoadjuvant Therapy 08/2023 - 09/2008
4	Immunotherapy 01/2022 - 06/2014
3	Radiotherapy 02/2021 - 12/2015
2	Drug Tapering 01/2023 - 01/2023
1	Aftercare (After-Treatment) 03/2024
1	Cytoreduction Surgical Procedures 08/2023
1	Palliative Care (Palliative Therapy) 02/2021
1	Intravenous Infusions 07/2016
1	Combination Drug Therapy (Combination Chemotherapy) 06/2014
1	Maintenance Chemotherapy 06/2014